Abstract
In order to examine the relationship between heart dysfunction and subcellular abnormalities as well as molecular mechanisms during the development of diabetes, we studied changes in cardiac performance, myofibrillar as well as sarcoplasmic reticular (SR) activities, and cardiac gene expression at different time intervals upon inducing diabetes in rats by an injection of alloxan (65 mg/kg; i.v.). Cardiac dysfunction was associated with a depression in myofibrillar Ca2+-stimulated ATPase and changes in myosin isozyme composition at 2-12 weeks of inducing diabetes. A reduction in SR Ca2+-uptake and Ca2+-pump (SERCA2) activities was evident at 10 days to 12 weeks of inducing diabetes. Alterations in cardiac function during 2-12 weeks of diabetes show a linear relationship with changes in myofibrils and SR membranes. Furthermore, alterations in cardiac function as well as myofibrillar and SR activities in 4 week diabetic animals were normalized upon treatment with insulin for 4 weeks. The steady-state mRNA abundance for α-myosin heavy chain in the heart was decreased at 2 and 3 weeks but was unchanged at 5 and 6 weeks, whereas mRNA levels for β-myosin heavy chain remained elevated during 2-6 weeks after inducing diabetes. SERCA2 mRNA abundance in diabetic heart was significantly increased at 3 and 5 weeks but was unaltered at 2 and 6 weeks. These results support the view that heart dysfunction in diabetes may be a consequence of myofibrillar and SR abnormalities; however, defects in myofibrillar proteins, unlike those in the SR membranes, appear to be due to changes in their gene expression.
Similar content being viewed by others
References
Dhalla NS, Pierce GN, Innes IR, Beamish RE: Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol 1: 263–281, 1985
Kessler I: Mortality experience of diabetic patients. Am J Med 51: 715–717, 1971
Afzal N, Pierce GN, Elimban V, Beamish RE, Dhalla NS: Influence of verapamil on some subcellular defects in diabetic cardiomyopathy. Am J Physiol 256: E453–E458, 1989
Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS: Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 244: E528–E535, 1983
Lopaschuk GD, Tahiliani AG, Vadlamudi RVSV, Katz S, McNeill JH: Cardiac sarcoplasmic reticulum function in insulin-or carnitine-treated diabetic rats. Am J Physiol 245: H969–H976, 1984
Penpargkul S, Fein F, Sonnenblick EH, Scheuer J: Depressed sarcoplasmic reticular function for diabetic rats. J Mol Cell Cardiol 13: 303–309, 1981
Pollack PS, Malhotra A, Fein FS, Scheuer J: Effects of diabetes on cardiac contractile proteins in rabbits and reversal with insulin. Am J Physiol 251: H448–H454, 1996
Regan TJ: Congestive heart failure in the diabetic. Ann Rev Med 34: 161–168, 1983
Heimberg M, Meng HC, Park CR: Effect of sex, fasting and alloxan diabetes on the uptake of neutral fat by isolated perfused rat liver. Am J Physiol 195: 673–677, 1958
Solaro RJ, Pang DC, Briggs FN: The purification of cardiac myofibrils with Triton X-100. Biochim Biophys Acta 245: 259–2621, 1971
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidiniun thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159, 1987
Pierce GN, Dhalla NS: Sarcolemmal Na+-K+-ATPase activity in diabetic rat heart. Am J Physiol 245: C241–C247, 1983
Harigaya S, Schwartz A: Rate of calcium binding and uptake in normal animal and failing human cardiac muscle: Membrane vesicles (relaxing system) and mitochondria. Circ Res 25: 781–794, 1969
Hoh JFY, McGrath PA, Hole PT: Electrophoretic analysis of multiple forms of rat cardiac myosin, effect of hypohysectomy and thyroxine replacement. J Mol Cell Cardiol 10: 1053–1076, 1978
Pierce GN, Dhalla NS: Mechanisms of the defect in cardiac myofibrillar function during diabetes. Am J Physiol 248: E170–E175, 1985
Dillman WH: Diabetes-induced changes in specific proteins and mRNAs in the rat heart. In: N. Nagano, N.S. Dhalla (eds). The Diabetic Heart. Raven Press Ltd., New York, 1991, pp 263–270
Malhotra A, Penpargkul S, Fein FS, Sonnenblick EH, Scheuer J: The effect of streptozotocin-induced diabetes in rats on cardiac contractile proteins. Circ Res 49: 1243–1250, 1981
Lopaschuk GD, Tahiliani AG, Vadlamudi RVSV: The effect of alloxan and streptozotocin induced diabetes on calcium transport in cardiac sarcoplasmic reticulum. The possible involvement of long chain acylcarnitines. Can J Physiol Pharmacol 61: 439–448, 1984
Takeda N, Dixon IMC, Hata T, Elimban V, Shah KR, Dhalla NS: Sequence of alterations in subcellular organelles during the development of heart dysfunction in diabetes. Diabetes Res Clin Prac 30(suppl): S113–S122, 1996
Dhalla NS, Das PK, Sharma GP: Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol 10: 363–383, 1978
Golfinan L, Dixon IMC, Takeda N, Lukas A, Dakshinamurti K, Dhalla NS: Cardiac sarcolemmal Na+-Ca+ exchange and Na+-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats. Mol Cell Biochem 188: 91–101, 1998
Katagiri T, Umezawa Y, Suwa Y, Geshi E, Yanagishita T, Yaida M: Biochemical and morphological alterations in cardiac myocytes in streptozotocin-induced diabetic rats. In: M. Nagano, S. Mochizuki, N.S. Dhalla (eds). Cardiovascular Disease in Diabetes. Kluwer Academic Publishers, Boston, MA, 1992, pp 139–153
Russ M, Reinauer H, Eckel J: Diabetes-induced decrease in the mRNA coding for sarcoplasmic reticulum Ca2+ ATPase in adult rat cardiomyocytes. Biochem Biophys Res Commun 178: 906–912, 1991
Zarain-Herzberg A, Yano K, Elimban V, Dhalla NS: Cardiac sarcoplasmic reticulum Ca2+ ATPase expression in streptozotocin-induced diabetic rat heart. Biochem Biophys Res Commun 203: 113–120, 1994
Arai M, Matsui H, Periasarny M: Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 74: 555–564, 1994
Hasenfuss G, Reinecke H, Studer P, Meyer M, Piesche M, Holtz J, Holubarsch C, Posival H, Just H, Drexler H: Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+ ATPase in failing and nonfailing human myocardium. Circ Res 75: 434–442, 1994
Matsui H, MacLennan DH, Alpert NP, Periasamy M: Sarcoplasmic reticulum gene expression in pressure-overload cardiac hypertrophy in rabbit. Am J Physiol 268: C252–C258, 1995
Schwartz K, Carrier L, Lompre AM, Mercadier JJ, Boheler KR: Contractile proteins in sarcoplasmic reticulum Ca2+-ATPase gene expression in the hypertrophied and failing heart. Basic Res Cardiol 87: 285–290, 1992
Zarain-Herzberg A, Afzal N, Elimban V, Dhalla NS: Decreased expression of cardiac sarcoplasmic reticulum Ca2+-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem 163/164: 285–290, 1996
Dillmann WH, Barrieux A, Shanker R: The influence of thyroid hormone on myosin heavy chain mRNA and other messenger RNAs in the rat heart. Endocrine Res 15: 5165–577, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Golfman, L., Dixon, I.M., Takeda, N. et al. Differential changes in cardiac myofibrillar and sarcoplasmic reticular gene expression in alloxan-induced diabetes. Mol Cell Biochem 200, 15–25 (1999). https://doi.org/10.1023/A:1006950218597
Issue Date:
DOI: https://doi.org/10.1023/A:1006950218597